• No se han encontrado resultados

The A1chieve study An observational non interventional study of patients with type 2 diabetes initiating or changing to insulin analogue therapy: data from the Argentinean population

N/A
N/A
Protected

Academic year: 2020

Share "The A1chieve study An observational non interventional study of patients with type 2 diabetes initiating or changing to insulin analogue therapy: data from the Argentinean population"

Copied!
14
0
0

Texto completo

Loading

Figure

TABLA I. Características de los pacientes para la cohorte completa y según el tratamiento
Figura 1. Nivel de hemoglobina glicosilada A 1c  (HbA 1c  %) para la cohorte completa y
TABLA II. Control del nivel de glucosa y del peso corporal para la cohorte completa y según el tratamiento previo al inicio
Figura 2. Eventos hipoglucémicos por paciente-año en la cohorte completa
+2

Referencias

Documento similar

Method: This article aims to bring some order to the polysemy and synonymy of the terms that are often used in the production of graphic representations and to

Protein tyrosine phosphatase 1B (PTP1B) is a negative regulator of insulin signaling and a therapeutic target for type 2 diabetes (T2DM). In this study, we have evaluated the role

The aim of this study was to analyse the performance and the semantic organization of patients with anorexia nervosa (AN) and of healthy controls by means of a “Human Body Parts”

– Spherical Mexican hat wavelet on the sphere software (developed by the Observational Cosmology and Instrumentation Group at

Prospective observational study evaluating the association of 124 polymorphisms with the response to adalimumab or infliximab (PASI75) in patients with moderate-to-severe

The increment in the glucose metabolic index at the lower insulin infusion rate over that observed under basal condi- tions can be compared with the maximal increment obtained

Evidence from experimental and observational studies, especially the findings of the Strategies for Management of Anti-Retroviral Therapy Study (SMART Study), 46 have

Fortunately, physicians appear to be aware of the need to monitor CVD risk in patients with active RA: a study of 14,503 patients in world-wide data from the SUrvey of